Welcome to our dedicated page for Cemtrex SEC filings (Ticker: CETX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cemtrex Inc. filings document a public operating company with Security, Industrial, and Aerospace & Defense activities, including governance matters, capital-structure transactions, acquisitions, and material agreements. Proxy filings cover shareholder voting and corporate governance, while current reports record completed business acquisitions, registered direct offerings, common stock and pre-funded warrant issuances, and Series 1 Preferred Stock dividend treatment.
The filing record also includes acquisition disclosures for Invocon and Richland Industries, including asset or share purchase agreements, completion reports, financing arrangements, and related financial statement or pro forma information. These documents describe how acquired operations are incorporated into Cemtrex’s industrial services and aerospace-defense platforms, alongside the company’s ongoing securities and reporting obligations.
Cemtrex, Inc. is implementing a reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on June 5, 2026, following prior stockholder approval. As of this filing, the company has 11,121,834 shares of common stock outstanding.
The move is intended to help Cemtrex regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a closing bid price of at least $1 per share for ten consecutive business days. After the split, common stock will trade on a split-adjusted basis under the same symbol, CETX, with a new CUSIP number 15130G865.
Fractional shares will not be issued; most fractional positions will be rounded up, but very small pre-split holdings can be rounded down. The company also discloses 3,975,653 outstanding Adjustable Warrants at an exercise price of $0.75 per share, whose terms will lower the post-split exercise price and significantly increase the number of underlying shares.
Cemtrex, Inc. reported results for the quarter ended March 31, 2026 with revenue of $18.1 million, down from $27.3 million a year earlier, but posted net income attributable to stockholders of $907,048, largely influenced by non‑operating items.
For the first six months of fiscal 2026, revenue was $34.2 million versus $41.0 million in the prior‑year period, and Cemtrex recorded a net loss of $19.6 million. Cash used in operating activities was $5.3 million, while financing activities provided $20.9 million, including a $10.0 million equity offering and warrant exercises.
The company completed two acquisitions: Invocon, Inc. for cash consideration of $7.06 million (recognizing $3.98 million of goodwill and $3.13 million of intangible assets) and the assets of Richland Industries LLC with total preliminary consideration of $5.44 million and a recorded bargain purchase gain of $2.07 million.
Despite ending the quarter with $7.9 million in cash, cash equivalents and restricted cash and total assets of $70.7 million, management disclosed that recurring large net losses, including $28.1 million in fiscal 2025 and substantial debt obligations of $10.8 million due over the next fiscal year, raise substantial doubt about Cemtrex’s ability to continue as a going concern.
Cemtrex Inc. held its Annual Meeting of Shareholders on May 15, 2026, where shareholders voted on board elections and auditor ratification. As of the March 17, 2026 record date, there were 116,513,938 total voting shares. At the meeting, 107,636,697 voting shares were represented, a 92.38% quorum.
Shareholders elected four directors—Saagar Govil, Brian Kwon, Manpreet Singh, and Mitodi Filipov—with each receiving over 102.7 million votes for and small abstain counts, plus 4,399,719 broker non-votes. Shareholders also ratified Grassi & Co. as independent registered public accounting firm for the fiscal year ending September 30, 2026, with 107,273,002 votes for, 125,857 against, and 237,838 abstentions.
Cemtrex Inc. has called its 2026 annual shareholder meeting for May 15, 2026 at the Hyatt Regency Long Island to elect four directors and ratify Grassi & Co. as independent auditor. Shareholders of record as of March 17, 2026 can vote in person or by proxy.
Voting power is heavily influenced by preferred stock: 10,078,089 common shares carry 10,078,089 votes, 50,000 Series C Preferred shares carry 100,881,671 votes, and 2,776,819 Series 1 Preferred shares carry 5,553,638 votes, for a total of 116,513,398 votes. Saagar Govil is Chairman and CEO, with three independent directors serving on the audit committee.
The proxy details significant related-party arrangements, including royalty-based sale terms for Cemtrex XR businesses to the CEO and receivables from entities controlled by current and former executives, as well as continued net losses and pay-versus-performance data for named executive officers.
Cemtrex Inc. filed an amended current report to add detailed financial statements and proforma information for its acquisition of Invocon Inc.. Cemtrex completed the deal on January 8, 2026, acquiring 100% of Invocon for $7,060,000 in cash, largely funded with new debt.
Invocon generated $3,783,978 in revenue and a net loss of $310,539 for the year ended December 31, 2024, then improved to revenue of $4,382,819 and net income of $647,551 for the nine months ended September 30, 2025. Proforma, the combined company would have had revenue of $81,764,777 and a net loss attributable to Cemtrex shareholders of $29,347,873 for the year ended September 30, 2025, reflecting added interest expense from the acquisition financing and preliminary goodwill recognition.
Cemtrex, Inc. announced that its Board of Directors has approved paying the upcoming dividend on its Series 1 Preferred Stock in additional shares of Series 1 Preferred Stock rather than in cash. The dividend will be issued on April 7, 2026 to holders of record at the close of business on March 31, 2026.
Holders of the Series 1 Preferred Stock are entitled to receive dividends at a rate of 10% annually, based on the $10.00 per share preference amount, with payments made on a semiannual schedule. Using stock to satisfy this dividend preserves cash while still honoring the stated preferred dividend terms.
Cemtrex, Inc. approved a reverse stock split. The Board and holders by majority written consent authorized a reverse split at a ratio between 1-for-3 and 1-for-50, with the Board able to set the exact whole-number ratio at any time within 12 months after the consent.
The approval was by written consent on February 27, 2026 for holders of record as of March 6, 2026. As of that record date, 10,078,089 shares of Common Stock were outstanding; the total voting power eligible was 116,513,398 votes, and holders representing 101,219,376 votes (approximately 86.87%) voted in favor. The Board retains discretion whether and when to file the Certificate of Amendment to effect the Reverse Split and may abandon it prior to filing.
Cemtrex, Inc. has notified stockholders that holders holding a majority of voting power approved, by written consent, authorization for the Board to implement a reverse split of common stock at a ratio between 1-for-3 and 1-for-50, exercisable at the Board's discretion for 12 months.
The action was approved by holders controlling 101,219,376 votes (approx. 86.87%) of the 116,513,398 total voting power as of the Record Date. The Board may file the Certificate of Amendment to effect the split; timing and final ratio are at the Board's sole discretion. The reverse split is described as a tool to help maintain Nasdaq listing compliance and to permit flexibility, but it may not increase market capitalization and could affect liquidity and warrant adjustments.
Cemtrex, Inc. reported a larger-than-normal quarterly loss despite higher sales. For the three months ended December 31, 2025, revenue rose to $16.1 million from $13.7 million, but net loss was still $20.6 million, driven mainly by $12.1 million of interest expense and $4.7 million of warrant-related losses.
Cash and cash equivalents increased sharply to $20.5 million, helped by $5.7 million of warrant exercises, $6.0 million of equity offerings, and a $7.0 million note. Common shares outstanding jumped to 8.6 million at December 31, 2025, and 10.1 million by February 13, 2026, reflecting significant dilution.
Management explicitly states that recurring losses of $28.1 million in fiscal 2025, a $20.6 million quarterly loss, and $6.7 million of debt due within a year raise substantial doubt about Cemtrex’s ability to continue as a going concern. Subsequent to quarter-end, Cemtrex completed a $7.06 million cash acquisition of Invocon and a Tennessee industrial services acquisition funded with new bank debt and a $4.9 million mortgage.
Cemtrex Inc. investors reported a significant ownership position in the company’s common stock. As of the close of business on December 31, 2025, the reporting persons may be deemed to beneficially own 605,011 shares of common stock issuable upon exercise of a warrant, representing approximately 7.3% of the class.
This percentage is based on 7,711,663 shares of common stock outstanding as of December 29, 2025, plus the warrant shares. The position is held through Intracoastal Capital LLC and attributed to Mitchell P. Kopin and Daniel B. Asher, who share voting and dispositive power and certify the holding is not for changing control.